Thromboysis for pulmonary embolism during pregnancy . About four cases

##plugins.themes.academic_pro.article.sidebar##

Published Jun 25, 2018
Download
pdf
Vol. 96 No. 1 (2018): Issue Jan 2018

##plugins.themes.academic_pro.article.main##

Nejeh Ben Halima
Ahmed Sghaier
Houssem Thabet
Yossra Mesaouadi
Houssem Ragmoun

Abstract

Pregnancy is correlated with a significant increase in the risk of pulmonary embolism (PE) given the physiological changes in fibrinolysis and mechanical stress induced by the pregnant uterus. Our goal is to demonstrate through four cases of massive bilateral PE occurred during pregnancy, the possibility of thrombolysis in pregnant women. We report the observation of four pregnant patients, between 28 and 38 years old and whose term varies between nine and 36 last menstrual period, hospitalized for serious PE complicated by cardiorespiratory arrest in one case and haemodynamic instability in other cases. Pulmonary angioscan was performed in three cases and transesophageal echocardiography in a patient with cardiogenic shock. Thrombolysis based on rtPA was performed in all cases, with a favorable evolution in 3 cases. No maternal or fetal complication has been observed during pregnancy or on follow-up that ranges from two to seven years. These findings underscore the safety and efficacy of thrombolysis, which remains the only life-saving therapeutic method immediately available in these severe forms of PE during pregnancy. The risk of bleeding induced by pregnancy should not be a contraindication

Keywords:

Pulmonary embolism, pregnancy, thrombolysis.

##plugins.themes.academic_pro.article.details##

References

  1. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001; 119(1 suppl):122S-131S.
  2. Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy- related mortality in the United States,1987-1990. Obstet Gynecol. 1996;88:161-167.
  3. Thromboemoblic disease in pregnancy and the puerperium: acute management. RCOG. Green-top Guideline No. 28; 2007.
  4. M Ramin SM, Ramin KD, Gilstrap LC. Anticoagulants and thrombolytics during pregnancy. SeminPerinatol. 1997;21:149-153.
  5. Schutte JM, Steegers EAP, Schuitemaker NWE, Santema JG, de Boer K, Briet JW, Pel M, Vermeulen G, Visser W, Roosmalen J. Rise in maternal mortality in the Netherlands 1993-02.
  6. Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. EurRespir J 2005;26:864-74.
  7. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.
  8. Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med 2002;162:1221-7.
  9. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. ObstetGynecolSurv. 1995;50:534-541.
  10. Fennerty AG, Levine MN, Hirsh J. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest. 1989;95(2 suppl):88S-97S.